(Q34623991)

English

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial (English)
0 references
Christopher Bellamy
Alastair MacGilchrist
Dorothy H Crawford

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit